Genetic and serologic evaluation of capsule production by bovine mammary isolates of Staphylococcus aureus and other Staphylococcus spp. from Europe and the United States

Journal of Clinical Microbiology

Volumn 38, Issue 8, 2000, Pages 2998-3003

  Tollersrud, T ^a   Kenny, K ^a   Reitz A J , Jr ^a   Lee, J C ^a  

^a NORWEGIAN VETERINARY INSTITUTE   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE;

ARTICLE; BACTERIAL MEMBRANE; CARBOHYDRATE SYNTHESIS; CATTLE DISEASE; DNA HYBRIDIZATION; EUROPE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS INTERMEDIUS; STAPHYLOCOCCUS SIMULANS; STAPHYLOCOCCUS XYLOSUS; UNITED STATES;

STAPHYLOCOCCUS AUREUS;

EID: 0033891394     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.8.2998-3003.2000     Document Type: Article

References (40)

1. A study of phage-and ribotype patterns of Staphylococcus aureus isolated from bovine mastitis in the Nordic countries
2. Virulence of Staphylococcus aureus mutants altered in type 5 capsule production
3. Mastitis can take on several different forms
4. Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus
5. Staphylococcus aureus microcapsule expression attenuates bacterial virulence in a rat model of experimental endocarditis
6. Identification of a gene essential for O-acetylation of the Staphylococcus aureus type 5 capsular polysaccharide
7. Direct testing of blood culture for detection of the serotype 5 and 8 capsular polysaccharides of Staphylococcus aureus
8. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge
9. Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide
10. Prevalence of capsular serotypes among Staphylococcus aureus isolates from cows with mastitis in the United States
11. Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis
12. 2 inhibition in vitro and in vivo
13. Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8
14. Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus
15. Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes
16. Capsular polysaccharides of Staphylococcus aureus
17. Questions uniqueness of surface polysaccharide
18. Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus
19. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats
20. Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus
21. Genetic analysis of type 5 capsular polysaccharide expression by Staphylococcus aureus
22. Structural analysis of the surface polysaccharide of Staphylococcus aureus
23. In vivo-like antigenic surface properties of Staphylococcus aureus from bovine mastitis induced upon growth in milk whey
24. Species-specific and ubiquitous-DNA-based assays for rapid identification of Staphylococcus aureus
25. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen
26. Structure of the type 5 capsular polysaccharide of Staphylococcus aureus
27. The repeating sequence of the capsular polysaccharide of Staphylococcus aureus
28. Reactivity of type-specific monoclonal antibodies with Staphylococcus aureus clinical isolates and purified capsular polysaccharide
29. The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis
30. The expression of capsule in serum-soft agar by Staphylococcus aureus isolated from bovine mastitis
31. Prevalence of capsular polysaccharide types 5 and 8 among Staphylococcus aureus isolates from cow, goat, and ewe milk
32. Reactivity of coagulase-negative staphylococci isolated from cow and goat milk with monoclonal antibodies to Staphylococcus aureus capsular polysaccharide types 5 and 8
33. The Staphylococcus aureus allelic genetic loci for serotype 5 and 8 capsule expression contain the type-specific genes flanked by common genes
34. Encapsulatign and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types
35. Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: Genetic and epidemiological analyses
36. Staphylococcus aureus growth and type 5 capsular polysaccharide production in synthetic media
37. Phagocytosis of mastitis isolates of Staphylococcus aureus and expression of type 5 capsular polysaccharide are influenced by growth in the presence of milk
38. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model
39. Genetic analysis of the cap5 locus of Staphylococcus aureus
40. Expression of a pseudocapsule by Staphylococcus aureus: Influence of cultural conditions and relevance to mastitis